Increasing evidence from transcriptomic and proteomic analyses in various cancers indicates that elevated SHCBP1 expression is strongly linked to aggressive clinicopathological traits and poor patient prognoses (Table 1). The gene discussed is SHCBP1; the disease is cancer.